Clinical Study on Expression of Platelet Activating Factor (paf)and Changes of Activities of TXB2 and 6-K-pgf1α in Patients with Senile Diabetes

WANG De-zhong,WANG Gang,CHEN Yan
DOI: https://doi.org/10.3969/j.issn.1006-1533.2012.05.010
2012-01-01
Abstract:Objective:To observe the clinical significance of the expression of platelet activating factor(PAF) and activity changes of thromboxane B2(TXB2) and 6-keto-prostaglandin F1 α(6-K-PGF1α) in patients with senile diabetes mellitus.Methods:98 hospitalized cases(male and female 49 each) with senile diabetes mellitus were selected and divided into two groups(group A,without chronic vascular complications and group B,with chronic vascular complications).Control group was also designed.The expression of platelet activating factor(PAF) in blood,and the activity of thromboxane B2(TXB2),6-keto-prostaglandin F1 α(6-K-PGF1α) were determined.Results:Compared with those of control group,the expression of PAF,the activities of TXB2 and 6-K-PGF1α in plasma were all raised obviously in patients with senile diabetes mellitus.The results of group B were more obvious than those of group A.Conclusion:There were obvious increases in the expression of PAF,the activities of TXB2 and 6-K-PGF1αin patients with senile diabetes mellitus,which were more obvious in patients with chronic vascular complications.
What problem does this paper attempt to address?